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Correlations Between Corneal Biomechanical Properties
Measured With the Ocular Response Analyzer and ICare
Rebound Tonometry
Jorge Manuel Martins Jorge, PhD,* Jose M. Gonza´lez-Me´ijome, PhD,* Antonio Queiro´s, MD,*
Paulo Fernandes, MD,* and Manuel A. Paraﬁta, PhDw
Purpose: To investigate the biomechanical properties of the
normal cornea, and correlate them with central and peripheral
corneal thickness and age.
Methods: Seventy-six right eyes of volunteers were measured
with Ocular Response Analyzer (ORA), ICare rebound tono-
metry and an ultrasound pachymeter at corneal center and at
4mm from corneal center in the nasal and temporal directions.
Results: ICare readings were signiﬁcantly correlated with central
and peripheral corneal thickness and corneal biomechanical
properties. Corneal resistance factor was the biomechanical
parameter with the higher correlation with ICare intraocular
pressure (IOP) values. ICare tonometry at center and Goldmann
equivalent IOP obtained with ORA were signiﬁcantly higher for
thicker than thinner corneas (P<0.05). IOP compensated for
corneal properties with the ORA was lower than the remaining
IOP values measured in the study. Higher correlation was found
between Goldmann equivalent IOP with ORA and ICare IOP
values.
Conclusions: IOP values obtained with the rebound tonometer
are higher in thicker corneas and are positively correlated with
biomechanical corneal parameters, namely corneal resistance
factor. Although corneal thickness plays a signiﬁcant role in
rebound tonometry, elastic and viscous properties of the cornea
seem to play a signiﬁcant role in the interaction of the tonometer
probe with the ocular surface. However, the mechanism behind
this process is presently unknown.
Key Words: corneal biomechanics, Ocular Response Analyzer,
corneal thickness, rebound tonometry, intraocular pressure
(J Glaucoma 2008;17:442–448)
Intraocular pressure (IOP) measurements with conven-tional devices have demonstrated to be sensitive to
corneal thickness variations.1–3 In fact, patients with
reduced corneal thickness are at a higher risk of suﬀering
from normal or low tension glaucoma and glaucoma
damage.4,5 This is of major relevance in eyes that have
undergone refractive surgery.6 However, the biomecha-
nical properties of the cornea can also vary signiﬁcantly
without changes in corneal thickness and this could also
aﬀect IOP reliability. In fact, all tonometers that measure
through the application of a stress to the corneal tissue
are subject to the eﬀects of corneal resistance. This
corneal resistance is actually an ‘‘eﬀective property’’ type
of parameter. That is, rather than being a speciﬁc,
intrinsic mechanical parameter like Young’s modulus,
corneal resistance is a composite parameter that incorpo-
rates the material and geometric properties of the tissue,
including the time and spatial dependence of the under-
lying corneal material properties.7
Diﬀerent instruments have been recently developed
for the direct measure of the biomechanical properties of
the cornea. A review of those techniques can be found in
the literature.8 However, most recent approaches are
based on the noninvasive (air-puﬀ) or invasive (direct
contact of a tip) application of a controlled mechanical
stress.8,9 The Reichert ORA (Reichert Inc, Depew, NY)
determines corneal biomechanical properties using an
applied force-displacement relationship by an air-puﬀ
similar to that used in traditional noncontact tonometry.9
Parameters used to characterize the biomechanical
properties of the cornea include corneal hysteresis (CH)
and corneal resistance factor (CRF). CH depends on
the energy absorbed by the cornea when its tissue is
submitted to stress and relaxation, thus inducing a delay
in the corneal response to those forces.9 However, it is
necessary to consider that CH and CRF are composite
measures, which characterize the structural response of
the eye to the measurement device rather than intrinsic
material properties of the cornea, such as Young’s
modulus. This means that what we call ‘‘biomechanical
properties’’ do not represent a speciﬁc property of the
corneal tissue, but the response of the entire corneal
structure to the ORA’s measuring principle. As a result,
these properties are only measurable by the ORA—a
diﬀerent device could potentially provide some otherCopyright r 2008 by Lippincott Williams & Wilkins
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measure of biomechanical properties. In addition, ORA
provides 2 measurements of IOP, one that is equivalent to
Goldmann applanation tonometry (GAT) (IOPg) and the
other compensated for the corneal biomechanical proper-
ties of the cornea (IOPc).
Considering the new methods used for IOP mea-
surement as rebound tonometry, new concerns arise
because of the biomechanical properties of the cornea
and the potential inﬂuence of such properties on rebound
tonometry. ORA uses the delay of corneal response after
the applanation process to estimate the amount of energy
absorbed, and derivate viscous and elastic properties of
the cornea. In rebound tonometry, the absorbed energy
could also delay the corneal response when the impact is
applied to the cornea to measure IOP. According to this
assumption, we could hypothesize that rebound of a small
tip, as that used by the ICare tonometer (Tiolat Oy,
Helsinki, Finland), could be aﬀected by the biomechani-
cal properties of the cornea. Despite this, no signiﬁcant
changes in IOP were found at thicker corneal periphery in
normal corneas in the previous experiments carried out at
our group.10,11 A complete description of this instrument
and its functioning can be found in the literature.12–18
In the present study, the Reichert’s ORA was used
to evaluate the correlations between corneal biomechani-
cal properties with the IOP obtained with a rebound
tonometer.
MATERIALS AND METHODS
Seventy-six right eyes of volunteers were evaluated
with ORA and ICare rebound tonometer. ORA measure-
ments were taken centrally as recommended by the
manufacturer. Mean age was 33.0±11.8 within a range
from 19 to 60 years of age.
Inclusion criteria required that the subjects pre-
sented no corneal pathology or corneal scarring had
no previous ocular surgery nor were taking any ocular
medications. Despite some patients presented with high
IOP values, none of them were taking any medication as
this was the ﬁrst time they had been made aware of this
situation. After the purpose and procedures of the study
were fully explained, each patient gave the consent to
participate in the study. Study protocol followed the
tenets of the Declaration of Helsinki and was reviewed by
the Ethics Committee of the University of Minho.
ICare rebound tonometry was measured centrally
(ICc) and at 2 peripheral locations along the horizontal
meridian in the nasal (ICn) and temporal regions (ICt).
Peripheral measurements were taken at approximately
2mm from limbus. In addition, ultrasound corneal
thickness measurements at approximately the same
locations (CTc, CTn, and CTt) were obtained with a
Tomey SP-100 Handy (Tomey, Nagoya, Japan), whose
accuracy and repeatability had been recently assessed.19
Pachometry examinations were carried out after the
application of topical tetracaine hydrochloride (0.5%).
After sterilization using hydrogen peroxide (3%) and
rinsing with saline, an ultrasound probe was applied as
perpendicular as possible to the cornea. Triplicate
measurements were taken consecutively. To ensure
precision in repositioning ultrasound probe at peripheral
locations, all measurements were taken by the same
investigator with the aid of a ﬁxation panel. The patient
was seated with the head placed on a chinrest 0.8m away
from the ﬁxation panel. While their probe remains in the
same position as it was when measuring central thickness,
the eye turns to ﬁxate each of the corresponding light-
emitting diode’s on the panel so that the probe can be
placed at discrete locations over the cornea. Simple
equations deﬁne the trigonometric relationship between
the position of the ﬁxation light-emitting diode’s on the
panel and the corneal location to be measured. This
method has been probed to oﬀer good reproducibility
in peripheral computed tomography (CT) measure-
ments.20–23 Tonometry measurements with ORA and
ICare in a randomized order were always taken before
ultrasound pachometry. All instruments were calibrated
before commencement of the study.
Data were analyzed using the statistical package
SPSS version 14.0 (SPSS Inc, Chicago, IL). Normality
of data was evaluated with Kolmogorov-Smirnov test.
Diﬀerences between IOP values with ORA and ICare
were evaluated using 1-way analysis of variance (ANO-
VA) with Bonferroni post hoc correction. Parametric
correlations were used for normally distributed variables,
whereas nonparametric (Kruskall-Wallis) tests were used
when normal distribution could not be assumed. Correla-
tion coeﬃcients were used to quantify the correlations
among biomechanical, tonometric, and pachometric
measurements, respectively. The sample was divided into
2 groups according to median central corneal thickness
value. Values of IOP and biomechanical properties were
compared for thinner and thicker corneas using 1-way
ANOVA. The level of signiﬁcance was established at
a=0.05.
RESULTS
Descriptive statistics for the parameters measured in
the study are presented in Table 1. Corneal thickness
measurements were signiﬁcantly diﬀerent between the 3
corneal positions measured with peripheral nasal and
temporal readings being thicker than central ones
(ANOVA; P<0.001); furthermore, nasal thickness was
also signiﬁcantly higher than temporal thickness taken at
the same distance from limbus (ANOVA; P<0.001). The
3 ICare readings were also signiﬁcantly diﬀerent between
the center and the periphery (Kruskall-Wallis, P=0.018)
with temporal IOP being signiﬁcantly higher than nasal
and central readings. In addition, IOP readings were
highly correlated among each other (Pearson coeﬃ-
cient>0.800; P<0.001).
Patient’s age was positively correlated with IOPg
(0.406, P<0.001), IOPc (0.392, P<0.001), corneal
resistance factor (CRF) (0.277, P<0.015), and ICc
(0.246, P<0.033), but not with corneal thickness in any
of the 3 locations measured (P>0.1).
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Figure 1 displays a graphical representation of the
IOP values obtained with the ORA and ICare. Temporal
IOP obtained with ICare was signiﬁcantly higher than
IOPg and IOPc obtained with ORA (ANOVA, P=0.001
and P<0.001, respectively). Marginally signiﬁcant diﬀer-
ences were also detected between ICare IOP readings
obtained in the nasal and temporal locations (ANOVA,
P=0.028). From this graphic representation, we can
conclude that ICare displays higher and more variable
results than ORA. IOPg and IOPc seem to be more
reliable with the lower interquartile ranges and the least
diﬀerences between maximum and minimum values and
no outliers.
Regarding the agreement between IOP values
obtained with ORA and ICare, stronger correlations
were found between IOPg than IOPc, although all
correlations were high and statistically signiﬁcant
(P<0.001). Regression analysis presented in Figure 2
depicts the same results.
Table 2 displays the signiﬁcant correlations among
the biomechanical parameters (CRF and CH) and the
remaining parameters under investigation. Stronger
correlations were found for CRF than for CH with the
IOP values obtained with the ICare rebound tonometer.
These relationships are illustrated in Figure 3.
Correlations of the ICare IOP readings with corneal
thickness are presented in Table 3 with both parameters
being signiﬁcantly correlated, particularly with corneal
thickness at center and nasal locations. Figure 4 shows
the relationship between ICare readings and corneal
thickness. Despite the signiﬁcance of correlation and
regression analyses, this relationship is weaker than that
observed with CRF presented in Table 2 and Figure 3.
Median value for central corneal thickness was
540 mm. The sample was divided into 2 groups and the
diﬀerent values of IOP were averaged to evaluate if any
diﬀerence was present among thinner (r540 mm) and
thicker corneas (>540 mm). Values as presented in Figure
5. According to this division, IOPg, CRF, CH, ICc, ICn,
and ICt were signiﬁcantly higher for thicker than thinner
corneas (ANOVA, P<0.05). An additional statistical
analysis was repeated by splitting the eyes into groups
considering grouping the eyes into 4 groups of equal
number by corneal thickness and assigning the lower
quartile to the thin cornea group, and the highest quartile
to the thick cornea group not to bias the results by
inclusion of the central group of patients that have neither
thin nor thick corneas. According to this analysis, thin
corneas were considered as CT &<510 mm and thick
corneas as having CT >561 mm but the results were the
same as for the previous cut-oﬀ criteria of 540 mm.
Conversely, IOPc did not display such a dependency
on central corneal thickness. This result is expected
TABLE 1. Descriptive Statistics for the Parameters Measured With ORA, ICare, and US Pachometry
Instrument Measure ID Mean
Standard
Deviation Minimum Maximum
ORA (mm Hg)
IOP IOPg IOPg 15.47 3.43 8.40 23.20
IOPc IOPc 15.61 3.06 9.00 22.90
BP CRF CRF 10.68 1.97 5.50 16.60
CH CH 10.73 1.69 6.90 15.50
ICare rebound tonometer (mm Hg) Center ICc 17.17 4.04 8.00 27.00
Nasal ICn 16.83 3.89 10.00 29.00
Temporal ICt 18.57 4.28 8.00 30.00
Ultrasound pachometer (mm) Center CTc 535.69 35.08 448.33 610.67
Nasal CTn 609.24 38.69 537.00 698.33
Temporal CTt 574.80 38.43 484.00 662.33
Circles represent outliers.
n=76.
BP indicates biomechanical properties.
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FIGURE 1. Boxplots of IOP values and statistical comparison
among each other. ANOVA, post hoc Bonferroni corrected
P values. *Mean values are statistically significant (ANOVA,
P<0.05). **Mean values are statistically significant (ANOVA,
P<0.001).
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because IOPc is designed to compensate for the overall
biomechanical response of the cornea, in which central
corneal thickness plays a role.
DISCUSSION
Regression analysis showed that ICare measures
have higher correlation with biomechanical properties of
the cornea as represented by the CRF (Table 2) than
corneal thickness itself (Table 3). Previous studies have
also reported a trend for ICare IOP overestimation in
thicker corneas.18 However, to the best of our knowledge,
this is the ﬁrst study analyzing the central and peripheral
correlations between ICare IOP and corneal thickness
with the corneal biomechanical properties.
CH and corneal thickness demonstrated a much
higher correlation than in previous studies.5 However,
CH did not demonstrate a correlation with ICare
readings as high as did CRF, but a signiﬁcant correlation
was still found between CH and ICare IOP measured in
the temporal cornea. CH is a function of the energy
absorbed by the corneal tissue during applanation and
relaxation. Energy absorption could also aﬀect the
measurement with the ICare tonometer as this measure-
ment correlates with the inverse of the probe’s decelera-
tion speed after the impact with the cornea. This could
explain the relationship obtained between ICare IOP and
CRF, and at a lower level with CH. This relationship was
not present with Goldmann tonometry where a contact
method, not impact as in rebound tonometry, is used to
obtain the measurement. Theoretically, a cornea with
higher values of CH would display a longer delay in
response to stress and relaxation forces, which indirectly
means that it absorbs more energy when the air-puﬀ is
directed towards its tissue. For an impact based method
of IOP measurement, this would mean that the higher the
CH, the higher the ICare reading would be assuming that
a higher amount of energy absorbed by the cornea would
induce a more rapid deceleration in the tip displacement.
This is in fact the trend we have found in the present
study. On the other hand, less attention has been paid to
the ORA’s CRF.
According to the ORA’s inventor, CH is more
directly linked to the elastic properties of the cornea
whereas the CRF is a measurement of the cumulative
ORA IOPc (mmHg)
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FIGURE 2. Relationship between ICare and ORA IOP.
TABLE 2. Significant Correlations of Biomechanical
Parameters CRF and CH Obtained With the ORA With the
Remaining Parameters Measured in the Study
Correlation
Coeﬃcient
Statistical Signiﬁcance
(2-tailed)
CRF vs.
CH 0.779* P<0.001
ICc 0.699* P<0.001
ICn 0.489* P<0.001
ICt 0.702* P<0.001
CTc 0.696* P<0.001
CTn 0.627* P<0.001
CTt 0.629* P<0.001
CH vs.
ICc 0.287* P=0.012
ICn 0.078* NS
ICt 0.358w P=0.002
CTc 0.609w P<0.001
CTn 0.519w P<0.001
CTt 0.567w P<0.001
n=76.
*Spearman coeﬃcient (nonparametric correlation).
wPearson coeﬃcient (parametric correlation).
J Glaucoma  Volume 17, Number 6, September 2008 Correlations Between ICare and Corneal Biomechanical Properties
r 2008 Lippincott Williams & Wilkins 445
eﬀects of viscous and elastic resistance encountered by the
air-puﬀ during the aplanation of the corneal surface.7,9
Regarding to the correlation with IOP, CRF is positively
related with IOP, increasing at signiﬁcantly elevated
pressures. Conversely, no change or a slight decrease in
CH has been documented for higher IOP values. The
highly signiﬁcant positive correlation between ICare
readings and CRF could indicate that ICare readings
are aﬀected by other corneal properties and not only by
corneal viscous properties. However, the isolated impact
of corneal thickness, elastic and viscous tissue properties
in IOP values obtained by rebound tonometry and other
methods is presently unknown.
The stronger correlation found in the present study
between ICare IOP values and Goldmann (GAT)
equivalent IOP value (IOPg) agrees with previous studies
on the relationships between conventional and portable
GAT with ICare.16,17 Conversely, the lower correlation
found when ICare IOP values were correlated to IOP
compensated for the corneal properties (IOPc) suggests
that ICare readings are aﬀected by corneal properties and
not only by the actual IOP of the eye. The higher
correlation of IOP with biomechanical properties than
corneal thickness agrees with the theories postulated by
previous investigators,24 and suggests that corneal re-
sponse to stress and relaxation forces during tonometric
measurements is much more complex than an anatomical
question related to corneal thickness changes.5,25
In previous experiments conducted at our group, we
were unable to ﬁnd a consistent relationship between IOP
values measured with the rebound tonometer and
increased peripheral corneal thickness in normal cor-
neas10,11; in fact 80% of the eyes displayed peripheral
values within ±1mm Hg of the central reading. More-
over, in many situations, we could even obtain higher
values of IOP within the thinner central cornea than at
thicker corneal periphery. Similar results were obtained in
the present sample. In another study, comprising a larger
number of patients within a wide range of ages, we had
observed that ICare readings decreased with age, and this
decrease was signiﬁcant for peripheral readings.10 In this
study, we were not able to reproduce the results obtained
previously. However, the spectrum of age is signiﬁcantly
more limited in this occasion. Considering all data
presently available, we can conclude that the ICare
rebound tonometer is not sensitive to increased peripheral
corneal thickness as previously measured in other
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FIGURE 3. Regression analysis of IOP obtained with ICare at
different corneal locations and CRF measured with ORA.
TABLE 3. Significant Correlations of IOP Values Obtained
With the ICare Rebound Tonometer With the Remaining
Parameters Measured in the Study
Correlation Coeﬃcient Statistical Signiﬁcance (2-tailed)
ICc vs.
CTc 0.466* P<0.001
CTn 0.417* P<0.001
CTt 0.419* P<0.001
ICn vs.
CTc 0.167* NS
CTn 0.245* P=0.034
CTt 0.154* NS
ICt vs.
CTc 0.476w P<0.001
CTn 0.459w P<0.001
CTt 0.419w P<0.001
Correlations among ICare readings are not displayed but they are statistically
signiﬁcant. Correlations between ICare measurements and biomechanical proper-
ties of the cornea have been presented in Table 2.
n=76.
*Spearman coeﬃcient (nonparametric correlation).
wPearson coeﬃcient (parametric correlation).
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studies10,11; but at the same time thicker corneas have, on
average, higher IOP values with the same instrument. We
could hypothesize that for a certain cornea, with its
particular physiologic, histologic, and microstructural
characteristics, a signiﬁcant increase in thickness in the
periphery does not cause a signiﬁcantly diﬀerent response
to the impact of the ICare tonometer. We believe that
‘‘individual physiologic variations in corneal material
properties (the elastic and viscoelastic responses) may be a
more important determinant of corneal structural re-
sponse than corneal thickness.’’ This is consistent with the
arising common thought that complex relationships
between corneal thickness and biomechanical properties
of the cornea could aﬀect the IOP readings.
To elucidate the potential eﬀect of corneal proper-
ties other than corneal thickness in rebound tonometry,
further investigations should be carried out involving
patients aﬀected of diﬀerent corneal conditions as
keratoconus, corneal thinning because of refractive
surgery, or chronic corneal edema.
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